PortfoliosLab logoPortfoliosLab logo
KBGGY vs. NVO
Performance
Return for Risk
Dividends
Drawdowns
Volatility
Financials

Performance

KBGGY vs. NVO - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Kongsberg Gruppen ASA (KBGGY) and Novo Nordisk A/S (NVO). The values are adjusted to include any dividend payments, if applicable.

Loading graphics...

KBGGY vs. NVO - Yearly Performance Comparison


2026 (YTD)202520242023
KBGGY
Kongsberg Gruppen ASA
75.04%19.00%164.60%-2.54%
NVO
Novo Nordisk A/S
-25.80%-39.22%-15.93%21.90%

Fundamentals

Returns By Period

In the year-to-date period, KBGGY achieves a 75.04% return, which is significantly higher than NVO's -25.80% return.


KBGGY

1D
1.83%
1M
6.80%
YTD
75.04%
6M
42.08%
1Y
54.05%
3Y*
5Y*
10Y*

NVO

1D
-0.73%
1M
-0.01%
YTD
-25.80%
6M
-36.19%
1Y
-43.88%
3Y*
-20.88%
5Y*
3.69%
10Y*
5.04%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

KBGGY vs. NVO — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

KBGGY
KBGGY Risk / Return Rank: 6363
Overall Rank
KBGGY Sharpe Ratio Rank: 6464
Sharpe Ratio Rank
KBGGY Sortino Ratio Rank: 6666
Sortino Ratio Rank
KBGGY Omega Ratio Rank: 7272
Omega Ratio Rank
KBGGY Calmar Ratio Rank: 6060
Calmar Ratio Rank
KBGGY Martin Ratio Rank: 5353
Martin Ratio Rank

NVO
NVO Risk / Return Rank: 1010
Overall Rank
NVO Sharpe Ratio Rank: 88
Sharpe Ratio Rank
NVO Sortino Ratio Rank: 1111
Sortino Ratio Rank
NVO Omega Ratio Rank: 1010
Omega Ratio Rank
NVO Calmar Ratio Rank: 1111
Calmar Ratio Rank
NVO Martin Ratio Rank: 1111
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

KBGGY vs. NVO - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Kongsberg Gruppen ASA (KBGGY) and Novo Nordisk A/S (NVO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


KBGGYNVODifference

Sharpe ratio

Return per unit of total volatility

0.66

-0.81

+1.48

Sortino ratio

Return per unit of downside risk

1.44

-0.99

+2.43

Omega ratio

Gain probability vs. loss probability

1.23

0.86

+0.37

Calmar ratio

Return relative to maximum drawdown

0.87

-0.82

+1.69

Martin ratio

Return relative to average drawdown

1.18

-1.41

+2.60

KBGGY vs. NVO - Sharpe Ratio Comparison

The current KBGGY Sharpe Ratio is 0.66, which is higher than the NVO Sharpe Ratio of -0.81. The chart below compares the historical Sharpe Ratios of KBGGY and NVO, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Loading graphics...

Sharpe Ratios by Period


KBGGYNVODifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

0.66

-0.81

+1.48

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

0.10

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

0.16

Sharpe Ratio (All Time)

Calculated using the full available price history

1.29

0.46

+0.83

Correlation

The correlation between KBGGY and NVO is 0.13, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


Dividends

KBGGY vs. NVO - Dividend Comparison

KBGGY's dividend yield for the trailing twelve months is around 3.32%, less than NVO's 4.94% yield.


TTM20252024202320222021202020192018201720162015
KBGGY
Kongsberg Gruppen ASA
3.32%5.82%1.18%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
NVO
Novo Nordisk A/S
4.94%3.31%1.68%1.00%1.20%1.35%1.87%2.14%1.45%1.52%2.87%0.92%

Drawdowns

KBGGY vs. NVO - Drawdown Comparison

The maximum KBGGY drawdown since its inception was -68.35%, smaller than the maximum NVO drawdown of -74.70%. Use the drawdown chart below to compare losses from any high point for KBGGY and NVO.


Loading graphics...

Drawdown Indicators


KBGGYNVODifference

Max Drawdown

Largest peak-to-trough decline

-68.35%

-74.70%

+6.35%

Max Drawdown (1Y)

Largest decline over 1 year

-68.35%

-55.03%

-13.32%

Max Drawdown (5Y)

Largest decline over 5 years

-74.70%

Max Drawdown (10Y)

Largest decline over 10 years

-74.70%

Current Drawdown

Current decline from peak

-37.27%

-73.49%

+36.22%

Average Drawdown

Average peak-to-trough decline

-18.68%

-17.56%

-1.12%

Ulcer Index

Depth and duration of drawdowns from previous peaks

50.45%

31.83%

+18.62%

Volatility

KBGGY vs. NVO - Volatility Comparison

Kongsberg Gruppen ASA (KBGGY) has a higher volatility of 14.32% compared to Novo Nordisk A/S (NVO) at 9.39%. This indicates that KBGGY's price experiences larger fluctuations and is considered to be riskier than NVO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading graphics...

Volatility by Period


KBGGYNVODifference

Volatility (1M)

Calculated over the trailing 1-month period

14.32%

9.39%

+4.93%

Volatility (6M)

Calculated over the trailing 6-month period

39.46%

38.79%

+0.67%

Volatility (1Y)

Calculated over the trailing 1-year period

82.01%

54.16%

+27.85%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

62.34%

37.82%

+24.52%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

62.34%

32.28%

+30.06%

Financials

KBGGY vs. NVO - Financials Comparison

This section allows you to compare key financial metrics between Kongsberg Gruppen ASA and Novo Nordisk A/S. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


30.00B40.00B50.00B60.00B70.00B80.00B90.00BJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025AprilJulyOctober
67.28B
(KBGGY) Total Revenue
(NVO) Total Revenue
Values in USD except per share items